Sonova enters strategic alliance with French biotech company to treat hearing loss

In December last year, Sonova dished out almost EUR 5m to Sensorion, a French biotech company specialized in the treatment of hearing disorders. Now, the two companies are entering into a strategic partnership with the goal of improving diagnostics and treatment through genetic analysis.
Arnd Kaldowsk, CEO at Sonova | Photo: Sonova / PR/Daniel Hager Photography & Film
Arnd Kaldowsk, CEO at Sonova | Photo: Sonova / PR/Daniel Hager Photography & Film
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY DANIEL PEDERSEN

A French-Swiss alliance for hearing loss treatment has been formed.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading